Top

Published in:

Open Access 01-12-2022 | Insomnia | Research

A comparison of cognitive behavioral therapy for insomnia to standard of care in an outpatient substance use disorder clinic embedded within a therapeutic community: a RE-AIM framework evaluation

Authors: Traci J. Speed, Lisa Hanks, Gavin Turner, Evelyn Gurule, Alexandra Kearson, Luis Buenaver, Michael T. Smith, Denis Antoine

Published in: Trials | Issue 1/2022

Abstract

Background

Rates of substance use disorders (SUDs) continue to rise in the USA with parallel rises in admissions to outpatient SUD treatment programs. Insomnia symptoms reduce treatment adherence, trigger relapse, and generally undermine SUD recovery efforts. Cognitive-behavioral therapy for insomnia (CBT-I) is the first-line treatment recommended for chronic insomnia. No study has examined the effectiveness of CBT-I for individuals who recently entered an outpatient SUD treatment program embedded within a therapeutic community (i.e., long-term drug-free residential setting).

Methods

A randomized controlled trial conducted at a SUD program embedded in a therapeutic community aimed to compare group-based CBT-I (gCBT-I) (N = 10) with the standard of care (SOC) (N = 11) among individuals who have SUDs and comorbid insomnia. We present a RE-AIM (reach, effectiveness, adoption, implementation, and maintenance) framework evaluation to provide empirical data on gCBT-I feasibility and facilitators and barriers of conducting an insomnia-focused clinical effectiveness study within a therapeutic community.

Results

Participants in both study arms reported moderately severe insomnia symptoms at admission and reductions in insomnia symptoms over time. Among participants who completed the Insomnia Severity Index (ISI) beyond admission, ISI decreased to ≤ 8 (the clinical cutoff for mild insomnia) in 80% of individuals in the gCBT-I group compared with 25% of individuals in the SOC group. A RE-AIM framework evaluation showed initial success with Reach and Adoption while Implementation, and Maintenance were limited. Effectiveness was inconclusive because of challenges with recruitment, intervention integrity, and missing data that precluded meeting the planned recruitment and study aims and led to study termination. Coordination and communication with staff and leadership facilitated gCBT-I implementation, yet well-known CBT-I barriers including time- and resource-intensive sleep medicine training for interventionalists and maintenance of treatment integrity during an 8-week intervention limited gCBT-I sustainability.

Conclusions

This analysis supports the feasibility of conducting behavioral sleep medicine research in outpatient SUD treatment programs embedded within therapeutic communities. Implementation of an insomnia-focused intervention was widely accepted by patients and providers and has potential to address insomnia symptoms in early SUD recovery. Addressing patient- and organizational-level implementation barriers may enhance the sustainability and scalability of sleep interventions and provide new hope to effectively treat insomnia among people living with SUDs.

Trial registration

Clinicaltrials.gov: NCT03208855. Registered July 6, 2017https://clinicaltrials.gov/ct2/show/NCT03208855?term=NCT03208855&draw=2&rank=1

National Survey of Substance Abuse Treatment Services (N-SSATS) - 2018. Available from: https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSSATS-2018.pdf

McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284:1689–95. https://doi.org/10.1001/jama.284.13.1689.CrossRefPubMed

Wallen GR, Brooks AT, Whiting B, Clark R, Krumlauf MC, Yang L, et al. The prevalence of sleep disturbance in alcoholics admitted for treatment: a target for chronic disease management. Fam Community Health. 2014;37:288–97. https://doi.org/10.1097/FCH.0000000000000040.CrossRefPubMedCentralPubMed

Zhabenko N, Wojnar M, Brower KJ. Prevalence and correlates of insomnia in a Polish sample of alcohol-dependent patients. Alcohol Clin Exp Res. 2012:1600–7. https://doi.org/10.1111/j.1530-0277.2012.01771.x.

Ohayon M. Epidemiological study on insomnia in the general population. Sleep. 1996;19:S7–15 Available from: https://www.ncbi.nlm.nih.gov/pubmed/8723370.CrossRefPubMed

Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep. 1999;22(Suppl 2):S347–53 Available from: https://www.ncbi.nlm.nih.gov/pubmed/10394606.PubMed

Hertenstein E, Feige B, Gmeiner T, Kienzler C, Spiegelhalder K, Johann A, et al. Insomnia as a predictor of mental disorders: a systematic review and meta-analysis. Sleep Med Rev. 2019;43:96–105. https://doi.org/10.1016/j.smrv.2018.10.006.CrossRefPubMed

Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA. 1989;262:1479–84. https://doi.org/10.1001/jama.262.11.1479.CrossRefPubMed

Weissman MM, Greenwald S, Niño-Murcia G, Dement WC. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry. 1997;19:245–50. https://doi.org/10.1016/s0163-8343(97)00056-x.CrossRefPubMed

10.

Janson C, Lindberg E, Gislason T, Elmasry A, Boman G. Insomnia in men—a 10-year prospective population based study. Sleep. 2001;24:425–30 [cited 2020 Apr 7]. Available from: https://academic.oup.com/sleep/article-abstract/24/4/425/2750026.CrossRefPubMed

11.

Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39:411–8 Available from: https://www.ncbi.nlm.nih.gov/pubmed/8679786.CrossRefPubMed

12.

Haario P, Rahkonen O, Laaksonen M, Lahelma E, Lallukka T. Bidirectional associations between insomnia symptoms and unhealthy behaviours. J Sleep Res. 2013;22:89–95. https://doi.org/10.1111/j.1365-2869.2012.01043.x.CrossRefPubMed

13.

Roncero C, Grau-Lopez L, Díaz-Morán S, Miquel L. Evaluation of sleep disorders in drug dependent inpatients. Medicina. 2012; europepmc.org; Available from: https://europepmc.org/abstract/med/22018396.

14.

Khazaee-Pool M, Pashaei T, Nouri R, Taymoori P, Ponnet K. Understanding the relapse process: exploring Iranian women’s substance use experiences. Subst Abuse Treat Prev Policy. 2019;14:27. https://doi.org/10.1186/s13011-019-0216-3.CrossRefPubMedCentralPubMed

15.

Brower KJ. Insomnia, alcoholism and relapse. Sleep Med Rev. 2003;7:523–39 Available from: https://www.ncbi.nlm.nih.gov/pubmed/15018094.CrossRefPubMed

16.

Wagman AM, Allen RP. Effects of alcohol ingestion and abstinence on slow wave sleep of alcoholics. Adv Exp Med Biol. 1975;59:453–66 Available from: https://www.ncbi.nlm.nih.gov/pubmed/1180154.CrossRefPubMed

17.

Sharma R, Sahota P, Thakkar MM. Alcoholism and sleep. the behavioral, molecular, pharmacological, and clinical basis of the sleep-wake cycle: Elsevier; 2019. p. 159–92. Available from: https://www.sciencedirect.com/science/article/pii/B9780128164303000099CrossRef

18.

Schierenbeck T, Riemann D, Berger M, Hornyak M. Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana. Sleep Med Rev. 2008;12:381–9. https://doi.org/10.1016/j.smrv.2007.12.004.CrossRefPubMed

19.

Asaad TA, Ghanem MH, Abdel Samee AM, El-Habiby MM. Sleep profile in patients with chronic opioid abuse: a polysomnographic evaluation in an Egyptian sample. Addict Disord Their Treat. 2011;10:21 [cited 2018 Sep 28]. Available from: https://journals.lww.com/addictiondisorders/Abstract/2011/03000/Sleep_Profile_in_Patients_With_Chronic_Opioid.4.aspx.CrossRef

20.

Angarita GA, Emadi N, Hodges S, Morgan PT. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addict Sci Clin Pract. 2016;11:9. https://doi.org/10.1186/s13722-016-0056-7.CrossRefPubMedCentralPubMed

21.

Nettleton S, Neale J, Pickering L. Techniques and transitions: a sociological analysis of sleeping practices amongst recovering heroin users. Soc Sci Med. 2011;72:1367–73. https://doi.org/10.1016/j.socscimed.2011.02.040.CrossRefPubMed

22.

Neale J, Nettleton S, Pickering L. The everyday lives of recovering heroin users. London: Royal Society of Arts; 2012. Available from: http://ww.williamwhitepapers.com/pr/UK%20Everyday%20Lives%20of%20Recovering%20Heroin%20Users%20Neale,%20Nettleton%20%26%20Pickering.pdf

23.

Short NA, Allan NP, Oglesby ME, Moradi S, Schmidt NB, Stecker T. Prospective associations between insomnia symptoms and alcohol use problems among former and current military service personnel. Drug Alcohol Depend. 2019;199:35–41. https://doi.org/10.1016/j.drugalcdep.2019.02.018.CrossRefPubMed

24.

Budney AJ, Moore BA, Vandrey RG, Hughes JR. The time course and significance of cannabis withdrawal. J Abnorm Psychol. 2003;112:393 Available from: https://psycnet.apa.org/record/2003-05990-008.CrossRefPubMed

25.

Budney AJ, Vandrey RG, Hughes JR, Thostenson JD, Bursac Z. Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. J Subst Abus Treat. 2008;35:362–8. https://doi.org/10.1016/j.jsat.2008.01.002.CrossRef

26.

Vandrey R, Smith MT, McCann UD, Budney AJ, Curran EM. Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal. Drug Alcohol Depend. 2011;117:38–44. https://doi.org/10.1016/j.drugalcdep.2011.01.003.CrossRefPubMedCentralPubMed

27.

Angarita GA, Canavan SV, Forselius E, Bessette A, Pittman B, Morgan PT. Abstinence-related changes in sleep during treatment for cocaine dependence. Drug Alcohol Depend. 2014;134:343–7. https://doi.org/10.1016/j.drugalcdep.2013.11.007.CrossRefPubMed

28.

Currie SR, Malhotra S, Clark S. Agreement among subjective, objective, and collateral measures of insomnia in postwithdrawal recovering alcoholics. Behav Sleep Med. 2004;2:148–61. https://doi.org/10.1207/s15402010bsm0203_4.CrossRefPubMed

29.

Brower KJ, Aldrich MS, Hall JM. Polysomnographic and subjective sleep predictors of alcoholic relapse. Alcohol Clin Exp Res. 1998;22:1864–71 Available from: https://www.ncbi.nlm.nih.gov/pubmed/9835309.CrossRefPubMed

30.

Smith N, Hill R, Marshall J, Keaney F, Wanigaratne S. Sleep related beliefs and their association with alcohol relapse following residential alcohol detoxification treatment. Behav Cogn Psychother. 2014;42:593–604. https://doi.org/10.1017/S1352465813000465.CrossRefPubMed

31.

Brower KJ, Perron BE. Sleep disturbance as a universal risk factor for relapse in addictions to psychoactive substances. Med Hypotheses. 2010:928–33. https://doi.org/10.1016/j.mehy.2009.10.020.

32.

Warden D, Subramaniam GA, Carmody T, Woody GE, Minhajuddin A, Poole SA, et al. Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth. Addict Behav. 2012;37:1046–53. https://doi.org/10.1016/j.addbeh.2012.04.011.CrossRefPubMedCentralPubMed

33.

Griffiths RR, Johnson MW. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. J Clin Psychiatry. 2005;66(Suppl 9):31–41 Available from: https://www.ncbi.nlm.nih.gov/pubmed/16336040.PubMed

34.

Murtagh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol. 1995;63:79–89 Available from: https://www.ncbi.nlm.nih.gov/pubmed/7896994.CrossRefPubMed

35.

Morin CM, Bastien C, Guay B, Radouco-Thomas M, Leblanc J, Vallières A. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry. 2004;161:332–42. https://doi.org/10.1176/appi.ajp.161.2.332.CrossRefPubMed

36.

Riedel B, Lichstein K, Peterson BA, Epperson MT, Means MK, Aguillard RN. A comparison of the efficacy of stimulus control for medicated and nonmedicated insomniacs. Behav Modif. 1998;22:3–28. https://doi.org/10.1177/01454455980221001.CrossRefPubMed

37.

Riemann D, Perlis ML. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev. 2009;13:205–14. https://doi.org/10.1016/j.smrv.2008.06.001.CrossRefPubMed

38.

Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry. 2002;159:5–11. https://doi.org/10.1176/appi.ajp.159.1.5.CrossRefPubMed

39.

Manber R, Bernert RA, Suh S, Nowakowski S, Siebern AT, Ong JC. CBT for insomnia in patients with high and low depressive symptom severity: adherence and clinical outcomes, vol. 12: FOC. American Psychiatric Publishing; 2014. p. 90–8. https://doi.org/10.1176/appi.focus.12.1.90.CrossRef

40.

Smith MT, Huang MI, Manber R. Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders. Clin Psychol Rev. 2005;25:559–92. https://doi.org/10.1016/j.cpr.2005.04.004.CrossRefPubMed

41.

Smith MT, Finan PH, Buenaver LF, Robinson M, Haque U, Quain A, et al. Cognitive-behavioral therapy for insomnia in knee osteoarthritis: a randomized, double-blind, active placebo-controlled clinical trial. Arthritis Rheum. 2015;67:1221–33. https://doi.org/10.1002/art.39048.CrossRef

42.

Ree M, Junge M, Cunnington D. Australasian Sleep Association position statement regarding the use of psychological/behavioral treatments in the management of insomnia in adults. Sleep Med. 2017;36(Suppl 1):S43–7. https://doi.org/10.1016/j.sleep.2017.03.017.CrossRefPubMed

43.

Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26:675–700. https://doi.org/10.1111/jsr.12594.CrossRefPubMed

44.

Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD, Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med Am Coll Physicians. 2016;165:125–33. https://doi.org/10.7326/M15-2175.CrossRef

45.

Wilkerson AK, Simmons RO, Sahlem GL, Taylor DJ, Smith JP, Book SW, et al. Sleep and substance use disorder treatment: a preliminary study of subjective and objective assessment of sleep during an intensive outpatient program. Am J Addict. 2021. https://doi.org/10.1111/ajad.13194.

46.

Arnedt JT, Conroy DA, Armitage R, Brower KJ. Cognitive-behavioral therapy for insomnia in alcohol dependent patients: a randomized controlled pilot trial. Behav Res Ther. 2011;49:227–33. https://doi.org/10.1016/j.brat.2011.02.003.CrossRefPubMedCentralPubMed

47.

Currie SR, Clark S, Hodgins DC, El-Guebaly N. Randomized controlled trial of brief cognitive-behavioural interventions for insomnia in recovering alcoholics. Addiction. 2004:1121–32. https://doi.org/10.1111/j.1360-0443.2004.00835.x.

48.

Chakravorty S, Morales KH, Arnedt JT, Perlis ML, Oslin DW, Findley JC, et al. Cognitive behavioral therapy for insomnia in alcohol-dependent veterans: a randomized, controlled pilot study. Alcohol Clin Exp Res. 2019;43:1244–53. https://doi.org/10.1111/acer.14030.CrossRefPubMedCentralPubMed

49.

Robabeh SM, Jafar MMM, Sharareh HM, Maryam HRM, Masoumeh EM. The effect of cognitive behavior therapy in insomnia due to methadone maintenance therapy: a randomized clinical trial. Iran J Med Sci. 2015;40:396–403 Available from: https://www.ncbi.nlm.nih.gov/pubmed/26379345.PubMed

50.

Vanderplasschen W, Colpaert K, Autrique M, Rapp RC, Pearce S, Broekaert E, et al. Therapeutic communities for addictions: a review of their effectiveness from a recovery-oriented perspective. ScientificWorldJournal. 2013;2013:427817. https://doi.org/10.1155/2013/427817.CrossRefPubMedCentralPubMed

51.

Malivert M, Fatséas M, Denis C, Langlois E, Auriacombe M. Effectiveness of therapeutic communities: a systematic review. Eur Addict Res. 2012;18:1–11. https://doi.org/10.1159/000331007.CrossRefPubMed

52.

De Leon G. The therapeutic community: theory, model, and method: Springer Publishing Company; 2000. Available from: https://play.google.com/store/books/details?id=mflOo0L-7fACCrossRef

53.

Staiger PK, Liknaitzky P, Lake AJ, Gruenert S. Longitudinal substance use and biopsychosocial outcomes following therapeutic community treatment for substance dependence. J Clin Med Res. 2020:9. https://doi.org/10.3390/jcm9010118.

54.

Yablonsky L. The therapeutic community: a successful approach for treating substance abusers: Gardner Press; 1989. Available from: https://play.google.com/store/books/details?id=2B9sAAAAMAAJ

55.

Gilbert JM, Hills S, Rife ML. Substance abuse treatment: group therapy. Treatment Improvement Protocol (TIP) Series 41. Substance Abuse and Mental Health Services Administration. ERIC; 2005; Available from: https://eric.ed.gov/?id=ED491570

56.

Lash SJ, Burden JL, Monteleone BR, Lehmann LP. Social reinforcement of substance abuse treatment aftercare participation: impact on outcome. Addict Behav. 2004;29:337–42. https://doi.org/10.1016/j.addbeh.2003.08.008.CrossRefPubMed

57.

Koffel EA, Koffel JB, Gehrman PR. A meta-analysis of group cognitive behavioral therapy for insomnia. Sleep Med Rev. 2015;19:6–16. https://doi.org/10.1016/j.smrv.2014.05.001.CrossRefPubMed

58.

Kwan BM, McGinnes HL, Ory MG, Estabrooks PA, Waxmonsky JA, Glasgow RE. RE-AIM in the Real World: Use of the RE-AIM framework for program planning and evaluation in clinical and community settings. Front Public Health. 2019;7:345 Available from: https://www.frontiersin.org/article/10.3389/fpubh.2019.00345.CrossRefPubMedCentralPubMed

59.

Glasgow RE, Harden SM, Gaglio B, Rabin B, Smith ML, Porter GC, et al. RE-AIM Planning and evaluation framework: adapting to new science and practice with a 20-year review. Front Public Health. 2019;7:64. https://doi.org/10.3389/fpubh.2019.00064.CrossRefPubMedCentralPubMed

60.

Glasgow RE, Estabrooks PE. Pragmatic applications of RE-AIM for health care initiatives in community and clinical settings. Prev Chronic Dis. 2018. https://doi.org/10.5888/pcd15.170271.

61.

Kleinman MB, Doran K, Felton JW, Satinsky EN, Dean D, Bradley V, et al. Implementing a peer recovery coach model to reach low-income, minority individuals not engaged in substance use treatment. Subst Abus. 2020:1–15. https://doi.org/10.1080/08897077.2020.1846663.

62.

Quanbeck A, Gustafson DH, Marsch LA, Chih M-Y, Kornfield R, McTavish F, et al. Implementing a mobile health system to integrate the treatment of addiction into primary care: a hybrid implementation-effectiveness study. J Med Internet Res. 2018;20:e37 [cited 2021 Feb 9]. Available from: https://www.jmir.org/2018/1/e37/.CrossRefPubMedCentralPubMed

63.

Quanbeck AR, Gustafson DH, Marsch LA, McTavish F, Brown RT, Mares M-L, et al. Integrating addiction treatment into primary care using mobile health technology: protocol for an implementation research study. Implement Sci. 2014;9:65. https://doi.org/10.1186/1748-5908-9-65.CrossRefPubMedCentralPubMed

64.

Chan-Goh SM, Hoeksel R, Sturgeon J, Murinova N. Evaluation of behavioral insomnia treatment in shared medical visit setting for migraineurs with comorbid insomnia: application of the RE-AIM framework (1914). Neurology. 2020;94 [cited 2021 Mar 23]. Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology; Available from: https://n.neurology.org/content/94/15_Supplement/1914.abstract.

65.

De Leon G. Community as method: therapeutic communities for special populations and special settings: Greenwood Publishing Group; 1997. Available from: https://play.google.com/store/books/details?id=vHQ_txwfJAkC

66.

Mee-Lee D. The ASAM Criteria. Chevy Chase: American Society of Addiction Medicine; 2013. Available from: https://www.gtc.edu/sites/default/files/hope/ASAM.Offuett.pdf

67.

Jones HE, Wong CJ, Tuten M, Stitzer ML. Reinforcement-based therapy: 12-month evaluation of an outpatient drug-free treatment for heroin abusers. Drug Alcohol Depend. 2005;79:119–28. https://doi.org/10.1016/j.drugalcdep.2005.01.006.CrossRefPubMed

68.

Tuten M, Shadur JM, Stitzer M, Jones HE. A comparison of reinforcement based treatment (RBT) versus RBT plus recovery housing (RBTRH). J Subst Abuse Treat. 2017;72:48–55. https://doi.org/10.1016/j.jsat.2016.09.001.CrossRefPubMed

69.

Jarvis M, Williams J, Hurford M, Lindsay D, Lincoln P, Giles L, et al. Appropriate use of drug testing in clinical addiction medicine. J Addict Med. 2017;11:163–73. https://doi.org/10.1097/ADM.0000000000000323.CrossRefPubMed

70.

Schramm E, Hohagen F, Grasshoff U, Riemann D, Hajak G, Weess HG, et al. Test-retest reliability and validity of the Structured Interview for Sleep Disorders According to DSM-III-R. Am J Psychiatry. 1993;150:867–72. https://doi.org/10.1176/ajp.150.6.867.CrossRefPubMed

71.

Morin CM, Belleville G, Bélanger L, Ivers H. The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011:601–8. https://doi.org/10.1093/sleep/34.5.601.

72.

Hartwell EE, Pfeifer JG, McCauley JL, Maria MM-S, Back SE. Sleep disturbances and pain among individuals with prescription opioid dependence. Addict Behav. 2014:1537–42. https://doi.org/10.1016/j.addbeh.2014.05.025.

73.

Ahlberg R, Skårberg K, Brus O, Kjellin L. Auricular acupuncture for substance use: a randomized controlled trial of effects on anxiety, sleep, drug use and use of addiction treatment services. Substance Abuse Treatment Prev Policy. 2016. https://doi.org/10.1186/s13011-016-0068-z.

74.

Hermes EDA, Rosenheck RA. Implementing computer-based psychotherapy among veterans in outpatient treatment for substance use disorders. Psychiatr Serv. 2016:176–83. https://doi.org/10.1176/appi.ps.201400532.

75.

Bastien C. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001:297–307. https://doi.org/10.1016/s1389-9457(00)00065-4.

76.

Smith S, Trinder J. Detecting insomnia: comparison of four self-report measures of sleep in a young adult population. J Sleep Res. 2001:229–35. https://doi.org/10.1046/j.1365-2869.2001.00262.x.

77.

Morin CM, Stone J, McDonald K, Jones S. Psychological management of insomnia: a clinical replication series with 100 patients. Behav Ther. 1994:291–309. https://doi.org/10.1016/s0005-7894(05)80289-8.

78.

Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA. 2001;285:1856–64 Available from: https://www.ncbi.nlm.nih.gov/pubmed/11308399.CrossRefPubMed

79.

Smith MT, Perlis ML, Haythornthwaite JA. Suicidal ideation in outpatients with chronic musculoskeletal pain. Clin J Pain. 2004:111–8. https://doi.org/10.1097/00002508-200403000-00008.

80.

Currie SR, Wilson KG, Pontefract AJ, deLaplante L. Cognitive–behavioral treatment of insomnia secondary to chronic pain. J Consult Clin Psychol. 2000:407–16. https://doi.org/10.1037/0022-006x.68.3.407.

81.

Monk TH, Petrie SR, Hayes AJ, Kupfer DJ. Regularity of daily life in relation to personality, age, gender, sleep quality and circadian rhythms. J Sleep Res. 1994:196–205. https://doi.org/10.1111/j.1365-2869.1994.tb00132.x.

82.

Coates TJ, Killen JD, Silverman S, George J, Marchini E, Hamilton S, et al. Cognitive activity, sleep disturbance, and stage specific differences between recorded and reported sleep. Psychophysiology. 1983:243–50. https://doi.org/10.1111/j.1469-8986.1983.tb02151.x.

83.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). Am Psych Pub. 2013; Available from: https://play.google.com/store/books/details?id=-JivBAAAQBAJ.

84.

Urbaniak GC, Plous S. Research randomizer; 1997. Available from: http://randomizer.org

85.

Perlis ML, Jungquist C, Smith MT, Posner D. Cognitive behavioral treatment of insomnia: a session-by-session guide: Springer Science & Business Media; 2006. Available from: https://play.google.com/store/books/details?id=xEeRnTkyPKMC

86.

Buenaver LF, Townsend D, Ong JC. Delivering cognitive behavioral therapy for insomnia in the real world: considerations and controversies. Sleep Med Clin. 2019;14:275–81. https://doi.org/10.1016/j.jsmc.2019.01.008.CrossRefPubMed

87.

Green LW, Glasgow RE. Evaluating the relevance, generalization, and applicability of research: issues in external validation and translation methodology. Eval Health Prof. 2006;29:126–53. https://doi.org/10.1177/0163278705284445.CrossRefPubMed

88.

Glasgow RE. Evaluating the impact of health promotion programs: using the RE-AIM framework to form summary measures for decision making involving complex issues. Health Educ Res. 2006:688–94. https://doi.org/10.1093/her/cyl081.

89.

Miller MA, Renn BN, Chu F, Torrence N. Sleepless in the hospital: a systematic review of non-pharmacological sleep interventions. Gen Hosp Psychiatry. 2019;59:58–66. https://doi.org/10.1016/j.genhosppsych.2019.05.006.CrossRefPubMedCentralPubMed

90.

Miller MB, Deroche CB, Freeman LK, Park CJ, Hall NA, Sahota PK, et al. Cognitive behavioral therapy for insomnia among young adults who are actively drinking: a randomized pilot trial. Sleep. 2021:44. https://doi.org/10.1093/sleep/zsaa171.

91.

Wilkerson AK, Sahlem GL, Bentzley BS, Lord J, Smith JP, Simmons RO, et al. Insomnia severity during early abstinence is related to substance use treatment completion in adults enrolled in an intensive outpatient program. J Subst Abus Treat. 2019;104:97–103. https://doi.org/10.1016/j.jsat.2019.06.003.CrossRef

92.

Troxel WM, Germain A, Buysse DJ. Clinical management of insomnia with brief behavioral treatment (BBTI). Behav Sleep Med. 2012;10:266–79. https://doi.org/10.1080/15402002.2011.607200.CrossRefPubMedCentralPubMed

93.

Holder N, Kanady JC, Straus LD, Khan AJ, Purcell N, Huggins J, et al. Reducing barriers to behavioral treatments for insomnia: a qualitative examination of veterans’ perspectives of BBTI. Behav Sleep Med. 2021:1–13. https://doi.org/10.1080/15402002.2021.1878173.

94.

of Health USD, Services H, Others. Health resources and services administration: National Center for Health Workforce Analysis; 2014. p. 2012–25.

Title: A comparison of cognitive behavioral therapy for insomnia to standard of care in an outpatient substance use disorder clinic embedded within a therapeutic community: a RE-AIM framework evaluation
Authors: Traci J. Speed
Lisa Hanks
Gavin Turner
Evelyn Gurule
Alexandra Kearson
Luis Buenaver
Michael T. Smith
Denis Antoine
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Insomnia
Care
Somnology
Somnology
Published in: Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-022-06885-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A comparison of cognitive behavioral therapy for insomnia to standard of care in an outpatient substance use disorder clinic embedded within a therapeutic community: a RE-AIM framework evaluation

Abstract

Background

Methods

Results

Conclusions

Trial registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2022

FORWARDS-1: an adaptive, single-blind, placebo-controlled ascending dose study of acute baclofen on safety parameters in opioid dependence during methadone-maintenance treatment—a pharmacokinetic-pharmacodynamic study

Optimising recruitment in clinical trials for progressive multiple sclerosis: observational analysis from the MS-SMART and MS-STAT2 randomised controlled trials

Intensity matters: protocol for a randomized controlled trial exercise intervention for individuals with chronic stroke

Efficacy of Emotionally Focused Therapy among Spanish-speaking couples: study protocol of a randomized clinical trial in Argentina, Costa Rica, Guatemala, Mexico, and Spain

What is the purpose of clinical trial monitoring?

Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India